◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Unicharm Corporation (8113) Net Income 2022–2025

Name: Unicharm Corporation (8113) net income history 2022-2025
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-08-12

Unicharm Corporation annual net income for fiscal 2025 was JPY 65.2 billion, a decrease of 20.3% from JPY 81.8 billion in fiscal 2024. All figures are reported results from public filings — no estimates or projections.

8113 Annual Net Income

Net Income (annual)	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Net Income	JPY 65.2B	JPY 81.8B	JPY 86.1B	JPY 67.6B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

8113 Quarterly Net Income

Net Income (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Net Income	JPY 21.3B	JPY 19.8B	JPY 4.5B	JPY 18.9B	JPY 16.9B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Net Income at Comparable Companies

4452 Net Income — Kao Corporation
4911 Net Income — Shiseido Company, Limited
4527 Net Income — Rohto Pharmaceutical Co.,Ltd.
4912 Net Income — Lion Corporation
4967 Net Income — Kobayashi Pharmaceutical Co., Ltd.
8283 Net Income — Paltac Corporation

More 8113 metrics: Revenue · Gross Profit · Operating Income · EPS · Free Cash Flow

All 8113 financial statements → Interactive 8113 charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.